6044 related articles for article (PubMed ID: 3137140)
1. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
Takada A; Sugawara Y; Takada Y
Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
[TBL] [Abstract][Full Text] [Related]
2. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
Eastman D; Wurm FM; van Reis R; Higgins DL
Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
Watahiki Y; Takada Y; Takada A
Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
[TBL] [Abstract][Full Text] [Related]
4. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
Takada A; Takada Y; Sugawara Y
Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
Fischer B
Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analyses of the enhancement of the activities of t-PA induced by the presence of monoclonal antibody (C9-5).
Sugawara Y; Takada Y; Yamamoto K; Takada A
Thromb Res; 1988 Jun; 50(5):637-46. PubMed ID: 3137683
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
Takada Y; Takada A
Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
Kruithof EK; Schleuning WD
Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
[TBL] [Abstract][Full Text] [Related]
9. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
[TBL] [Abstract][Full Text] [Related]
10. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
Takada A; Takada Y; Sugawara Y
Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
[TBL] [Abstract][Full Text] [Related]
11. [Plasminogen activation by a tissue activator and effector properties of fibrinogen-N-terminal disulfide (N-DSK) fibrin complex].
Makogonenko EM; Druzhina NN; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
Ukr Biokhim Zh (1978); 1991; 63(3):17-23. PubMed ID: 1926582
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
13. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
Takada A; Shizume K; Cho M; Takada Y
Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
[TBL] [Abstract][Full Text] [Related]
14. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
Takada A; Takada Y; Sugawara Y
Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
[TBL] [Abstract][Full Text] [Related]
15. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW
Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143
[TBL] [Abstract][Full Text] [Related]
16. Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.
Takada A; Takada Y; Sugawara Y
Thromb Res; 1984 Mar; 33(6):561-9. PubMed ID: 6539003
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin.
Takada A; Sugawara Y; Takada Y
Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
Liu JN; Gurewich V
Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
[TBL] [Abstract][Full Text] [Related]
20. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains.
Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ
Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
